Sign Out
Pregnancy: The effects of Imovax d.T. on embryo-foetal development have not been studied. No teratogenic effects have been observed after administration of diphtheria or tetanus toxoids to pregnant women.
Imovax d.T. should be used during pregnancy only if the expected benefits for the mother outweigh the potential risks, including those for the foetus.
Breast-feeding: The effects of vaccination of mothers on their breastfed children have not been studied. Imovax d.T. should only be used during breast-feeding when the potential benefits outweigh the potential risks.
Fertility: There are no data on the effect on fertility.
